Bioventus, Inc. (BVS)
12.91
+0.22
(+1.73%)
USD |
NASDAQ |
Oct 09, 12:45
Bioventus Gross Profit Margin (Quarterly) : 68.29% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 68.29% |
| March 31, 2026 | 67.88% |
| December 31, 2025 | 68.07% |
| September 30, 2025 | 66.95% |
| June 30, 2025 | 68.16% |
| March 31, 2025 | 65.76% |
| December 31, 2024 | 65.66% |
| September 30, 2024 | 65.83% |
| June 30, 2024 | 67.17% |
| March 31, 2024 | 66.91% |
| December 31, 2023 | 62.17% |
| September 30, 2023 | 63.36% |
| June 30, 2023 | 63.35% |
| March 31, 2023 | 60.30% |
| December 31, 2022 | 57.73% |
| Date | Value |
|---|---|
| September 30, 2022 | 63.95% |
| June 30, 2022 | 66.95% |
| March 31, 2022 | 61.77% |
| December 31, 2021 | 65.22% |
| September 30, 2021 | 70.89% |
| June 30, 2021 | 67.81% |
| March 31, 2021 | 70.47% |
| December 31, 2020 | 72.36% |
| September 30, 2020 | 70.62% |
| June 30, 2020 | 66.18% |
| March 31, 2020 | 70.46% |
| December 31, 2019 | 73.12% |
| September 30, 2019 | 71.22% |
| March 31, 2016 | 66.26% |
| March 31, 2015 | 63.69% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Accuray, Inc. | 34.76% |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 64.07% |
| Neogen Corp. | 37.03% |
| Orthofix Medical, Inc. | 69.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 26.76% |
| Return on Assets | 9.00% |
| Return on Invested Capital | 11.33% |
| Profit Margin (Quarterly) | 23.63% |
| Operating Margin (Quarterly) | 12.23% |
| Return on Net Operating Assets | 9.85% |